The enduring question of how best to alleviate poverty has spurred a surge in cash transfer programs, from city-level pilots to global initiatives. While these programs have demonstrably saved lives in many low- and middle-income countries, a puzzling disparity emerges when examining their impact within the United States: the same direct provision of funds yields surprisingly modest health gains. This isn’t a failure of the concept itself, but a critical mismatch between how cash assistance operates in different contexts, and a misunderstanding of the specific conditions required for it to truly transform health outcomes. Recent expansions of guaranteed income pilots, fueled by anxieties surrounding automation and economic inequality, have largely mirrored this pattern – enthusiasm outpacing demonstrable improvements in population health.
Why Cash Works Differently Across Borders
Drawn from theatlantic.com.
Dr. Emily Roberts, Health & Science Writer at OwlyTimes, has been studying the global landscape of cash transfer programs, and the findings reveal a consistent pattern. From a study encompassing 37 countries, a clear logic emerges: cash transforms health when four key conditions are met. These conditions are frequently absent in current U.S. pilot programs, explaining the divergent results. The fundamental principle is scale. In many low-income nations, even a relatively small monthly sum – around $20 or less – represents a substantial portion of a household’s income. This influx can immediately address critical needs like food, vaccinations, or access to essential medical care, directly impacting survival rates.
By contrast, a few hundred dollars per month, typical of many U.S. guaranteed income pilots, often falls short of covering the substantial costs of housing, childcare, and healthcare. While providing some financial relief, it rarely alters the fundamental constraints faced by low-income families. This isn’t to say the money is wasted; it’s simply that the impact is diluted by the sheer magnitude of existing financial burdens. The difference isn’t about willingness to spend wisely, but about the capacity to make meaningful change with the available resources.
The Specific Barriers to Health Matter
Beyond the amount of cash provided, the nature of the health challenges being addressed is crucial. In many developing countries, poverty is directly linked to preventable diseases like HIV, tuberculosis, malaria, and malnutrition. A small financial boost can overcome immediate barriers – transportation to clinics, access to nutritious food, or the ability to afford treatment. These are direct, solvable problems that cash can address.
The U.S., however, grapples with a different set of health crises: chronic diseases rooted in systemic inequities, environmental factors, and long-term exposures. While cash can reduce stress and improve financial stability, it cannot, on its own, undo decades of accumulated risk. The impact is most pronounced during specific life stages, such as pregnancy and early childhood, when access to basic needs and healthcare can dramatically alter health trajectories. This highlights a critical point: cash isn’t a universal panacea, but a targeted intervention best suited to address specific, poverty-related barriers to health.
SNAP: A Surprisingly Successful Model
Interestingly, one existing U.S. program consistently demonstrates the positive health impacts seen in international cash transfer programs: the Supplemental Nutrition Assistance Program (SNAP). SNAP’s success isn’t accidental. Its payments are substantial enough to meaningfully reduce poverty, directly address the barrier of food insecurity – a condition intrinsically linked to health – and reach over 40 million people. Furthermore, it’s integrated, albeit imperfectly, with other public systems like Medicaid and school meals, creating a network of support.
This integration is a key component of successful cash transfer programs globally. Brazil’s Bolsa Família program, for example, operates alongside a robust primary-care system, resulting in significant reductions in mortality. The contrast with many U.S. pilots, which operate in isolation, is stark. Recent attempts to restrict SNAP eligibility and funding, justified by claims of fraud (which represent a small fraction of overall spending, according to government estimates), are particularly concerning given its proven effectiveness. The One Big Beautiful Bill Act, for instance, moves directly against the lessons learned from successful programs.
Looking Beyond Pilots: Scaling What Works
While SNAP offers a valuable model, other programs also demonstrate the potential of well-designed cash assistance. The Earned Income Tax Credit (EITC), a lump-sum payment for low- and moderate-income workers, provides financial flexibility and has been linked to improved child health. The Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) combines food support with nutrition counseling and healthcare referrals, yielding positive birth outcomes and infant health.
More recently, the Rx Kids program in Flint, Michigan, launched in 2024, exemplifies the global playbook: meaningful transfer size, near-universal reach within the city, targeted benefits for pregnancy and infancy, and integration with the health system. Early evaluations suggest substantial improvements in birth outcomes, and Michigan’s subsequent investment to expand the program statewide demonstrates a viable path to scale. The question now isn’t whether cash assistance works, but whether we can replicate the conditions that make it effective – adequate funding, targeted interventions, and integration with existing social infrastructure – on a broader scale. What will be the long-term health impacts of the expanded Rx Kids program, and can its success be replicated in other states facing similar challenges? This is a critical area to watch as policymakers grapple with the future of poverty alleviation and public health.
